下一代定序儀市場：依細分市場劃分的規模、佔有率、法規、償付、安裝基礎、到2033年的預測

新一代定序儀是一種用於快速有效確定DNA或RNA鹼基序列的裝置。下一代定序儀為每次定序運行提供高效的通量，並能夠進行大規模並行處理，有助於闡明遺傳變異、了解複雜疾病、癌症基因組學、微生物學、進化生物學等，有助於推進該領域的研究。

測試大量突變以製定個人化治療策略現已成為標準，並且日益使用下一代定序來評估腫瘤活檢中各種潛在的可靶向突變。

本報告深入探討了全球下一代定序儀市場，包括競爭格局、SWOT 分析、到2033年的市場預測以及依地區和國家劃分的趨勢。

目錄

目前市面上的下一代定序儀及競爭狀況

• 對主要產業趨勢的見解
• 下一代定序儀依細分市場劃分的總市場收入以及2015年至2033年的市場前景
• 有關單位數量、平均售價和市場價值的詳細資料

全球、區域與國家見解

• 下一代定序儀市場的SWOT分析
• 次世代定序市場的競爭動態洞察與趨勢
• 各國醫療保健系統概覽
• 依國家/地區劃分的償付政策
• 各國醫療科技的監管狀況

Next Generation Sequencers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Next-generation sequencers are instruments used to determine the nucleotide sequence of DNA or RNA rapidly and efficiently. Offering an efficient throughput per sequencing, next-generation sequencers are capable of massively parallel processing and are instrumental in uncovering genetic variations, understanding complex diseases, and advancing research in areas such as cancer genomics, microbiology, and evolutionary biology.

The next-generation sequencers track the essential equipment only, and not accessories and/or additional costs associated with next-generation sequencer installation.

It is now standard to test for a high number of mutations to personalize treatment decisions, use of Next Generation Sequencers that can evaluate tumor biopsies for a wide range of potentially targetable mutations is increasing.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Next Generation Sequencers and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Next Generation Sequencers market revenue by segment and market outlooks from

2015- 2033

• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Next Generation Sequencers market.
• Competitive dynamics insights and trends provided for Next Generation Sequencers market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Illumina Inc, Pacific Biosciences, Thermo Fisher Scientific Inc, Singular Genomics System Inc , and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Next Generation Sequencers market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Next Generation Sequencers market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Next Generation Sequencers market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Next Generation Sequencers market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.